Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$914M |
| 2 |
Okta
OKTA
|
+$823M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$687M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$647M |
| 5 |
AT&T
T
|
+$636M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.24B |
| 2 |
Walt Disney
DIS
|
+$951M |
| 3 |
Ecolab
ECL
|
+$879M |
| 4 |
SPDR Gold Trust
GLD
|
+$558M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$505M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.05% |
| 2 | Healthcare | 10.24% |
| 3 | Financials | 9.62% |
| 4 | Communication Services | 7.72% |
| 5 | Consumer Discretionary | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
LCI Industries
LCII
$2.53B
| $14.8M | ﹤0.01% |
138,120
+30,817
| +29% | +$3.12M |
|
1952
Ciena
CIEN
$58.1B
| $14.8M | ﹤0.01% |
346,513
+86,375
| +33% | +$3.29M |
|
|
KIN
1953
DELISTED
Kindred Biosciences, Inc.
KIN
| $14.8M | ﹤0.01% |
1,742,415
-77,501
| -4% | -$605K |
|
1954
Markel Group
MKL
$23.3B
| $14.7M | ﹤0.01% |
12,871
+1,784
| +16% | +$2.03M |
|
1955
Vermilion Energy
VET
$1.7B
| $14.7M | ﹤0.01% |
898,746
-1,459,140
| -62% | -$22M |
|
1956
First American
FAF
$7.68B
| $14.7M | ﹤0.01% |
252,052
+128,886
| +105% | +$7.88M |
|
|
OPI
1957
DELISTED
Office Properties Income Trust
OPI
| $14.7M | ﹤0.01% |
457,224
+127,538
| +39% | +$4.09M |
|
1958
Tenaris
TS
$29.2B
| $14.7M | ﹤0.01% |
648,704
-927,469
| -59% | -$19.9M |
|
1959
Federal Signal
FSS
$7.95B
| $14.7M | ﹤0.01% |
455,062
-95,440
| -17% | -$3.11M |
|
1960
The GEO Group
GEO
$4.2B
| $14.6M | ﹤0.01% |
880,869
+115,030
| +15% | +$1.75M |
|
1961
Shutterstock
SSTK
$212M
| $14.6M | ﹤0.01% |
340,955
-70,591
| -17% | -$2.83M |
|
1962
Enanta Pharmaceuticals
ENTA
$394M
| $14.6M | ﹤0.01% |
236,158
+69,848
| +42% | +$4.33M |
|
|
IMMU
1963
DELISTED
Immunomedics Inc
IMMU
| $14.6M | ﹤0.01% |
689,381
+400,319
| +138% | +$7.06M |
|
1964
Check Point Software Technologies
CHKP
$12.6B
| $14.6M | ﹤0.01% |
131,185
-45,864
| -26% | -$5.15M |
|
1965
Silicon Laboratories
SLAB
$7.21B
| $14.5M | ﹤0.01% |
125,279
+80,592
| +180% | +$8.84M |
|
1966
Universal Health Services
UHS
$9.98B
| $14.5M | ﹤0.01% |
101,166
-205,040
| -67% | -$29.2M |
|
1967
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.03B
| $14.5M | ﹤0.01% |
220,858
+12,362
| +6% | +$783K |
|
1968
Cytokinetics
CYTK
$10.5B
| $14.5M | ﹤0.01% |
1,366,528
+1,090,420
| +395% | +$11.2M |
|
1969
McGrath RentCorp
MGRC
$2.95B
| $14.5M | ﹤0.01% |
189,017
+73,698
| +64% | +$5.35M |
|
1970
Takeda Pharmaceutical
TAK
$52.8B
| $14.5M | ﹤0.01% |
733,248
+161,005
| +28% | +$3.08M |
|
1971
ABM Industries
ABM
$2.88B
| $14.5M | ﹤0.01% |
383,530
+102,548
| +36% | +$3.83M |
|
1972
Corcept Therapeutics
CORT
$11.8B
| $14.4M | ﹤0.01% |
1,193,686
+192,832
| +19% | +$2.68M |
|
1973
First Trust NASDAQ ABA Community Bank Index Fund
QABA
$94.9M
| $14.4M | ﹤0.01% |
278,374
-3,462
| -1% | -$173K |
|
|
DOC
1974
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $14.4M | ﹤0.01% |
760,353
+51,360
| +7% | +$942K |
|
|
JPN
1975
DELISTED
Xtrackers Japan JPX-Nikkei 400 Equity ETF
JPN
| $14.4M | ﹤0.01% |
500,108
-5,779
| -1% | -$166K |
|
Similar funds
Morgan Stanley's Q4 2019 Portfolio in Review
As of Q4 2019, Morgan Stanley held 7,012 positions worth $430B, up 14% from $378B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley deployed $21.8B of net new capital in Q4 2019, opening 186 new positions and adding to 4,119 existing holdings. Its largest new stake was XChange TEC: 50 shares worth $44M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.24B trimmed.
- Morgan Stanley's largest Q4 2019 buy was XChange TEC: 50 shares worth $44M.
- Morgan Stanley added most to Uber in Q4 2019, an estimated $914M increase.
- Morgan Stanley's biggest Q4 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $1.24B.
- Morgan Stanley fully exited Buckeye Partners, L.P. in Q4 2019, selling an estimated $505M.
- Morgan Stanley's ten largest holdings make up 16% of its $430B portfolio in Q4 2019.
- Morgan Stanley opened 186 new positions and closed 188 in Q4 2019.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $430B.
Based on Morgan Stanley's 13F filing for Q4 2019, filed 14 Feb 2020.